The University of Pittsburgh Medical Center - Retinal Repair Cell Therapy's Unit Acquisition

The University of Pittsburgh Medical Center - Retinal Repair Cell Therapy raised a round of funding on February 06, 2017. Investors include BioTime.

The University of Pittsburgh Medical Center (UPMC) is a hospital that specializes in the treatment of a variety of diseases. UPMC develops and delivers life-changing medicine by working at the apex of…

Articles about The University of Pittsburgh Medical Center - Retinal Repair Cell Therapy's Unit Acquisition: